Tôi hân hạnh giới thiệu một công trình nghiên cứu mới được công bố trên tập san nội tiết học Journal of Clinical Endocrinology and Metabolism (JCEM). Đây là một bài phân tích tổng hợp (meta-analysis) về tác động của lượng cơ (nạc) và mỡ đến xương. Chủ đề này đã từng gây ra tranh cãi trong vòng 20 năm qua. Qua kết quả này, chúng tôi hi vọng đã có câu giải đáp sau cùng: đối với xương, lượng cơ quan trọng hơn lượng mỡ. Điều này có nghĩa là vai trò luyện tập thể dục là một phương án tốt nhất để phòng chống loãng xương. Dưới đây là thông cáo báo chí của Viện Garvan. (Đây cũng là công trình đầu tiên mà chúng tôi gắn bó với ĐH Tôn Đức Thắng). NVT
MUSCLE IS THREE TIMES BETTER THAN FAT FOR BONES
Garvan researchers in collaboration with Vietnamese colleagues have now shown that the impact of ‘lean mass’ is 3 times higher than the impact of ‘fat mass’, finally concluding a debate that has lasted for over 20 years.
Media Release: 20 January 2014
While it is well known that heavier people develop stronger bones, a burning issue for osteoporosis researchers over the last 20 years has been whether muscle or fat has the greater impact on bone mineral density. Australian and Vietnamese scientists have now shown that the impact of ‘lean mass’ is 3 times higher than the impact of ‘fat mass’, finally concluding the protracted debate.
The discussion started in July 1992 when a prominent group from the University of Auckland published a paper in the Journal of Clinical Endocrinology and Metabolism, demonstrating that body fat mass is the most significant predictor of bone density. The work has since been heavily cited, and has spawned dozens of other studies trying either to validate or disprove its findings.
Professor Tuan Nguyen from Sydney’s Garvan Institute of Medical Research, in collaboration with Dr Lan Ho-Pham, Head of Rheumatology at People’s Hospital 115 in Ho Chi Minh City, undertook a ‘meta-analysis’ of 44 studies, concluding that 21% of differences in bone mineral density can be explained by lean mass, 8% by fat mass. Ironically, their findings are also published in the Journal of Clinical Endocrinology and Metabolism, now online.
“In the presence of conflicting findings, meta-analysis is a good method of finally resolving the issue, and is a particularly popular tool in clinical medicine,” said Professor Nguyen.
“Conflicting findings in the medical literature are the norm rather than the exception, because studies are based on different populations and use different methodologies. The variability in findings between studies can be ’ironed out’ by the meta-analysis, which weights the relative importance of each study by its information content - sample size and quality of the data.”
“While it may seem as if we are splitting hairs by trying to determine which aspect of body weight plays the more influential role, the finding is actually very important for public health – because it will guide osteoporosis prevention. If muscle mass is critical, it makes sense to recommend improvement in physical activity and muscle-building exercise.”
The analysis also points out the differences in body composition and bone density between premenopausal women and postmenopausal women. In premenopausal women, lean mass is more important than fat mass, but in postmenopausal women the effect of lean mass is comparable with the effect of fat mass on bone density. It implies that hormones and nutrition are relevant factors for preventing postmenopausal osteoporosis. In Australia, approximately 30% of postmenopausal women have osteoporosis.
Another factor that determines bone density is genetics, which explain up to 75% of variance.
The discussion started in July 1992 when a prominent group from the University of Auckland published a paper in the Journal of Clinical Endocrinology and Metabolism, demonstrating that body fat mass is the most significant predictor of bone density. The work has since been heavily cited, and has spawned dozens of other studies trying either to validate or disprove its findings.
Professor Tuan Nguyen from Sydney’s Garvan Institute of Medical Research, in collaboration with Dr Lan Ho-Pham, Head of Rheumatology at People’s Hospital 115 in Ho Chi Minh City, undertook a ‘meta-analysis’ of 44 studies, concluding that 21% of differences in bone mineral density can be explained by lean mass, 8% by fat mass. Ironically, their findings are also published in the Journal of Clinical Endocrinology and Metabolism, now online.
“In the presence of conflicting findings, meta-analysis is a good method of finally resolving the issue, and is a particularly popular tool in clinical medicine,” said Professor Nguyen.
“Conflicting findings in the medical literature are the norm rather than the exception, because studies are based on different populations and use different methodologies. The variability in findings between studies can be ’ironed out’ by the meta-analysis, which weights the relative importance of each study by its information content - sample size and quality of the data.”
“While it may seem as if we are splitting hairs by trying to determine which aspect of body weight plays the more influential role, the finding is actually very important for public health – because it will guide osteoporosis prevention. If muscle mass is critical, it makes sense to recommend improvement in physical activity and muscle-building exercise.”
The analysis also points out the differences in body composition and bone density between premenopausal women and postmenopausal women. In premenopausal women, lean mass is more important than fat mass, but in postmenopausal women the effect of lean mass is comparable with the effect of fat mass on bone density. It implies that hormones and nutrition are relevant factors for preventing postmenopausal osteoporosis. In Australia, approximately 30% of postmenopausal women have osteoporosis.
Another factor that determines bone density is genetics, which explain up to 75% of variance.
ABOUT GARVAN
The Garvan Institute of Medical Research was founded in 1963. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with over 600 scientists, students and support staff. Garvan's main research areas are: Cancer, Diabetes & Obesity, Immunology and Inflammation, Osteoporosis and Bone Biology and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.
Media enquiries should be directed to:
Alison Heather
Science Communications Manager
M: + 61 434 071 326
P: +61 2 9295 8128
E: a.heather "a" garvan.org.au
The Garvan Institute of Medical Research was founded in 1963. Initially a research department of St Vincent's Hospital in Sydney, it is now one of Australia's largest medical research institutions with over 600 scientists, students and support staff. Garvan's main research areas are: Cancer, Diabetes & Obesity, Immunology and Inflammation, Osteoporosis and Bone Biology and Neuroscience. Garvan's mission is to make significant contributions to medical science that will change the directions of science and medicine and have major impacts on human health. The outcome of Garvan's discoveries is the development of better methods of diagnosis, treatment, and ultimately, prevention of disease.
Media enquiries should be directed to:
Alison Heather
Science Communications Manager
M: + 61 434 071 326
P: +61 2 9295 8128
E: a.heather "a" garvan.org.au
0 nhận xét:
Đăng nhận xét